Replimune Group, Inc.: Form 10-Q for the period ended Jun 30, 2026
Filed with the SEC on Aug 14, 2026 and accepted by EDGAR at Aug 14, 2026, 16:07 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2026-04-01 to 2026-06-30 | $49.3m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2026-04-01 to 2026-06-30 | $19.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2026-04-01 to 2026-06-30 | −$68.2m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2026-04-01 to 2026-06-30 | −$69.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-04-01 to 2026-06-30 | −$0.72 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-04-01 to 2026-06-30 | −$0.72 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-04-01 to 2026-06-30 | 96,864,452 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2026-04-01 to 2026-06-30 | −$75.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2026-04-01 to 2026-06-30 | $6.0k | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2026-06-30 | $185.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2026-06-30 | $200.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2026-06-30 | $252.4m | us-gaap:Assets |
| Current liabilities | At period end2026-06-30 | $38.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-06-30 | $146.8m | us-gaap:Liabilities |
| Long-term debt | At period end2026-06-30 | $84.1m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2026-06-30 | $105.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-26-057099. Last ingested by Listed: Oct 28, 2026, 07:26 ET. Listed shows no prices and gives no investment advice.